Introduction:
Chronic sinusitis is classified in ICD-11 CM as diagnostic code CA0A.1.
Chronic sinusitis is a long-standing inflammation of the mucosal lining of the paranasal sinuses that persists for 12 weeks or more, usually due to infectious or allergic causes. It is characterized by nasal obstruction, facial pain or pressure, nasal discharge, post-nasal drip, and reduction or loss of smell. The disease significantly affects patients’ quality of life and productivity, particularly among adults aged 21 to 40 years.
Homoeopathy, based on the principle of Individualization, recognizes that no two persons are identical even when suffering from the same disease. Each patient’s remedy is selected according to the totality of symptoms on the physical, emotional, and intellectual planes. The individualized approach aims to correct the internal imbalance responsible for chronic sinus inflammation rather than providing only symptomatic relief.
Hence, this study is undertaken to evaluate the effectiveness of individualization in homoeopathic management of chronic sinusitis among adults aged 21 to 40 years.

Epidemiology
Chronic rhinosinusitis affects approximately 134 million Indians (about 1 in 8 people). Its prevalence in urban areas ranges from 5 to 15 percent, and it is more frequent in the productive age group of 21 to 40 years. The disease imposes a substantial socioeconomic and emotional burden and often requires repeated medical intervention.

Aims and Objectives:

Primary Objective:

To assess the effectiveness of individualization in homoeopathic management of chronic sinusitis.

Other Objectives:

To compare pre-treatment and post-treatment scores in cases of chronic sinusitis using the validated SNOT-22 (Sino-Nasal Outcome Test) scale.

To study the clinical presentation of chronic sinusitis.

To analyse and evaluate the characteristic symptoms observed during the process of individualization.

Materials and Methodology:

Type of study design: A Prospective Non-Controlled Experimental Study

Study setting: Patients of chronic sinusitis will be enrolled from the Out-Patient Department of the institution.

Study population: Clinically pre-diagnosed patients of chronic sinusitis.

Duration of study: 18 months.

Methods of selection of study subjects

Inclusion Criteria

 Pre-diagnosed cases of chronic sinusitis (maxillary and/or frontal).
Patients of all genders aged 21 – 40 years.
  Patients willing to give written informed consent.

Exclusion Criteria
Patients with sinusitis with polyps.
Individuals suspected to be immunocompromised.
  Patients on another line of treatment for chronic sinusitis.
  Patients with systemic comorbidities.
  Pregnant and lactating females.

Subject Withdrawal Criteria

Patients with irregular follow-ups.

Patients who withdraw consent from the study.

Patients developing exclusion criteria during the study.

Patients taking any other medication during the treatment period.

Method of Selection of Comparison or Control Group  Not Applicable.
Matching Criteria  Not Applicable.

Specification of Instruments & Measurements

Standardized Homoeopathic Case Record.

Pre-validated SNOT-22 Scale.

The scale will be operated by a researcher; operator and assessor will be different.

Outcome Assessment Criteria

Clinical Outcome
Reduction in intensity and frequency of sinus symptoms such as nasal obstruction, facial pain, and nasal discharge.
Overall improvement of the patient as a whole based on physical generals and mental state.

Statistical Outcome
Comparison of pre-treatment and post-treatment scores on SNOT-22 Scale.

Improved: (Current SNOT-22 – Previous SNOT-22) < – 8.9

Not Improved: (Current SNOT-22 – Previous SNOT-22) > – 8.9

Sample Size 40 patients.
Sampling Technique  Non-Probability Purposive Sampling.

Methods of Data Collection

      Clinically pre-diagnosed patients will be enrolled from OPD based on inclusion and exclusion criteria.

   Detailed case-taking will be done as per standardized Homoeopathic proforma.

  Similimum will be selected on the basis of totality of symptoms and individualization according to     Kent’s philosophy.

Posology (potency and repetition) will be decided as per susceptibility in each case.

Duration

Duration of study  18 months.

Duration of each case  6 months.

Duration of follow-up  Every 15 days or earlier if required.

Statistical assessment At baseline, 3 months and 6 months after initiation of treatment.

Plan for Statistical Analysis

Data will be compiled in MS Excel and analysed using SPSS software.

Descriptive statistics such as frequency (n), percentage , mean and standard deviation will be applied.

Normality will be checked using the Shapiro–Wilk or Kolmogorov–Smirnov test.

Intragroup comparisons for normally distributed data will be done using paired t-test; for non-parametric data, Wilcoxon signed-rank test will be used.

Chi-square test will be applied to categorical data.

Alpha error 5%, Beta error 20%, Power 80%; p < 0.05 will be considered statistically significant.